291 related articles for article (PubMed ID: 8980621)
1. Local and systemic antibody levels against protein D of Haemophilus influenzae following immunization and infection in rats.
Akkoyunlu M; Forsgren A
APMIS; 1996 Oct; 104(10):709-17. PubMed ID: 8980621
[TBL] [Abstract][Full Text] [Related]
2. Bactericidal antibody response against P6, protein D, and OMP26 of nontypeable Haemophilus influenzae after acute otitis media in otitis-prone children.
Khan MN; Kaur R; Pichichero ME
FEMS Immunol Med Microbiol; 2012 Aug; 65(3):439-47. PubMed ID: 22463053
[TBL] [Abstract][Full Text] [Related]
3. A recombinant P4 protein of Haemophilus influenzae induces specific immune responses biologically active against nasopharyngeal colonization in mice after intranasal immunization.
Hotomi M; Ikeda Y; Suzumoto M; Yamauchi K; Green BA; Zlotnick G; Billal DS; Shimada J; Fujihara K; Yamanaka N
Vaccine; 2005 Jan; 23(10):1294-300. PubMed ID: 15652672
[TBL] [Abstract][Full Text] [Related]
4. Reduction of nasal colonization of nontypeable Haemophilus influenzae following intranasal immunization with rLP4/rLP6/UspA2 proteins combined with aqueous formulation of RC529.
Mason KW; Zhu D; Scheuer CA; McMichael JC; Zlotnick GW; Green BA
Vaccine; 2004 Sep; 22(25-26):3449-56. PubMed ID: 15308371
[TBL] [Abstract][Full Text] [Related]
5. Passive immunization with human anti-protein D antibodies induced by polysaccharide protein D conjugates protects chinchillas against otitis media after intranasal challenge with Haemophilus influenzae.
Novotny LA; Jurcisek JA; Godfroid F; Poolman JT; Denoël PA; Bakaletz LO
Vaccine; 2006 May; 24(22):4804-11. PubMed ID: 16616975
[TBL] [Abstract][Full Text] [Related]
6. Antibody against Haemophilus influenzae protein D in patients with chronic conditions causing secondary immunodeficiency.
Hawdon N; Biman B; McCready W; Brigden M; Malik S; Vergidis D; Kisselgoff O; Ulanova M
Vaccine; 2012 Feb; 30(7):1235-8. PubMed ID: 22230580
[TBL] [Abstract][Full Text] [Related]
7. Protein D of Haemophilus influenzae: a protective nontypeable H. influenzae antigen and a carrier for pneumococcal conjugate vaccines.
Forsgren A; Riesbeck K; Janson H
Clin Infect Dis; 2008 Mar; 46(5):726-31. PubMed ID: 18230042
[TBL] [Abstract][Full Text] [Related]
8. Intranasal immunization with outer membrane protein P6 and cholera toxin induces specific sinus mucosal immunity and enhances sinus clearance of nontypeable Haemophilus influenzae.
Sabirov A; Kodama S; Sabirova N; Mogi G; Suzuki M
Vaccine; 2004 Aug; 22(23-24):3112-21. PubMed ID: 15297063
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV).
Knuf M; Szenborn L; Moro M; Petit C; Bermal N; Bernard L; Dieussaert I; Schuerman L
Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S97-S108. PubMed ID: 19325452
[TBL] [Abstract][Full Text] [Related]
10. Local application of CpG oligodeoxynucleotide enhances nontypeable Haemophilus influenzae-specific mucosal IgA responses in the middle ear.
Kodama S; Hirano T; Abe N; Suzuki M
Acta Otolaryngol; 2007 Aug; 127(8):809-15. PubMed ID: 17762989
[TBL] [Abstract][Full Text] [Related]
11. Intranasal coinfection model allows for assessment of protein vaccines against nontypeable Haemophilus influenzae in mice.
Michel LV; Kaur R; Zavorin M; Pryharski K; Khan MN; LaClair C; O'Neil M; Xu Q; Pichichero ME
J Med Microbiol; 2018 Oct; 67(10):1527-1532. PubMed ID: 30136923
[TBL] [Abstract][Full Text] [Related]
12. Intranasal vaccination with recombinant P6 protein and adamantylamide dipeptide as mucosal adjuvant confers efficient protection against otitis media and lung infection by nontypeable Haemophilus influenzae.
Bertot GM; Becker PD; Guzmán CA; Grinstein S
J Infect Dis; 2004 Apr; 189(7):1304-12. PubMed ID: 15031801
[TBL] [Abstract][Full Text] [Related]
13. Intranasal immunization enhances clearance of nontypeable Haemophilus influenzae and reduces stimulation of tumor necrosis factor alpha production in the murine model of otitis media.
Sabirov A; Kodama S; Hirano T; Suzuki M; Mogi G
Infect Immun; 2001 May; 69(5):2964-71. PubMed ID: 11292713
[TBL] [Abstract][Full Text] [Related]
14. The role of Toll-like receptor 4 in eliciting acquired immune responses against nontypeable Haemophilus influenzae following intranasal immunization with outer membrane protein.
Hirano T; Kodama S; Moriyama M; Kawano T; Suzuki M
Int J Pediatr Otorhinolaryngol; 2009 Dec; 73(12):1657-65. PubMed ID: 19765832
[TBL] [Abstract][Full Text] [Related]
15. Prevention of otitis media: now a reality?
Schuerman L; Borys D; Hoet B; Forsgren A; Prymula R
Vaccine; 2009 Sep; 27(42):5748-54. PubMed ID: 19666154
[TBL] [Abstract][Full Text] [Related]
16. Investigation of the potential of a 48 kDa protein as a vaccine candidate for infection against nontypable Haemophilus influenzae.
Webb DC; Otczyk DC; Cripps AW
Vaccine; 2007 May; 25(20):4012-9. PubMed ID: 17379362
[TBL] [Abstract][Full Text] [Related]
17. Maternal intranasal immunization with outer membrane protein P6 maintains specific antibody level of derived offspring.
Yamauchi K; Hotomi M; Billal DS; Suzumoto M; Yamanaka N
Vaccine; 2006 Jun; 24(25):5294-9. PubMed ID: 16697503
[TBL] [Abstract][Full Text] [Related]
18. A single nasal dose of fms-like tyrosine kinase receptor-3 ligand, but not peritoneal application, enhances nontypeable Haemophilus influenzae-specific long-term mucosal immune responses in the nasopharynx.
Kodama S; Hirano T; Noda K; Abe N; Suzuki M
Vaccine; 2010 Mar; 28(13):2510-6. PubMed ID: 20117272
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the immunogenic property of NT H. influenzae protein D with Neisseria meningitidis OMV in BALB/c.
Behrouzi A; Bouzari S; Siadat SD; Oloomi M; Davari M; Mazaheri H
J Infect Dev Ctries; 2016 Dec; 10(12):1345-1351. PubMed ID: 28036315
[TBL] [Abstract][Full Text] [Related]
20. Nasal immunization with plasmid DNA encoding P6 protein and immunostimulatory complexes elicits nontypeable Haemophilus influenzae-specific long-term mucosal immune responses in the nasopharynx.
Kodama S; Hirano T; Noda K; Umemoto S; Suzuki M
Vaccine; 2011 Feb; 29(10):1881-90. PubMed ID: 21237276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
